arBtrage CAPITALIZING MARKETS checking… Sign in

Galectin Therapeutics Inc.

GALT Health Care Biotechnology: Pharmaceutical Preparations
$2.33
▼ -2.1% Today
as of Jun 7, 07:15 ET
Last 30 days +0.43% Apr 28 → Jun 05
$2.02 $2.23 $2.43 $2.64 $2.85 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$2.35
High
$2.40
Low
$2.25
Volume
$215,786
Avg Vol
$460,098
Mkt Cap
$169M
P/E (TTM)
Beta
52w High
$7.13
52w Low
$1.27
Div Yield
Shares Out
$66M

Overview

52-week range
$1.27
$7.13
18% of range
Avg surprise (last 1)
-33.3%
Avg reaction (last 2)
-3.1%
50% positive
Latest IV / EM
124%
EM ±17.2% · $3 · Jun 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.24$-0.20$-0.15$-0.10$-0.06 Actual $-0.15Actual $-0.24Actual $-0.19Actual $-0.20Actual $-0.18Actual $-0.15Actual $-0.12Actual $-0.13Actual $-0.08Est $-0.06 JunSepMarJunSepMar/2025JunSepMar/2026
Revenue vs Net Income Revenue Net income
$-12M$-11M$-9M$-7M$-5M Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Fri May 15, 2026Mar/2026 $-0.08 $-0.06 -33.3% +46.7% -7.7% earnings
Tue Sep 30, 2025Sep 2025 $-0.13 financials
Mon Jun 30, 2025Jun 2025 $-0.12 financials
Thu May 15, 2025Mar/2025 $-0.15 +1.5% earnings
Mon Sep 30, 2024Sep 2024 $-0.18 financials
Sun Jun 30, 2024Jun 2024 $-0.20 financials
Sun Mar 31, 2024Mar 2024 $-0.19 financials
Sat Sep 30, 2023Sep 2023 $-0.24 financials
Fri Jun 30, 2023Jun 2023 $-0.15 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue
Cost of revenue
Gross profit
Operating income$-4M$-4M$-5M$-8M$-9M$-11M
Net income$-5M$-8M$-8M$-10M$-11M$-12M
EPS (diluted)$-0.08$-0.13$-0.12$-0.15$-0.18$-0.20

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$14M$18M$12M$14M$7M$15M$27M$26M
Inventory
Total current assets$16M$19M$13M$15M$9M$17M$29M$27M
Total assets$16M$20M$13M$16M$10M$17M$29M$28M
Long-term debt
Total liabilities$146M$146M$136M$133M$122M$121M$121M$110M
Total equity$-132M$-128M$-125M$-119M$-114M$-105M$-94M$-84M

Implied volatility — last 90 days

118%121%123%126%128% Jun 07 — IV 124% · EM ±17.2%

Sector peers